/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Andrea Wang‐Gillam

Washington University in St. Louis(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

430

Papers

15.3K

Citations

48

h-index

125

i10-index

Andrea Wang‐Gillam is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Immunotherapy and Biomarkers & Cancer Genomics and Diagnostics. The author has an h-index of 48, co-authored 366 publications.

ORCID: 0000-0003-0458-7614

Research Topics

Pancreatic and Hepatic Oncology Research Cancer Immunotherapy and Biomarkers Cancer Genomics and Diagnostics Colorectal Cancer Treatments and Studies Cancer Research and Treatments

Papers by this author

works

Safety and Survival With GVAX Pancreas Prime and <i>Listeria Monocytogenes</i>–Expressing Mesothelin (CRS-207) Boost Vaccines for Metastatic Pancreatic Cancer

2015 · Journal of Clinical Oncology · 588 citations

https://doi.org/10.1200/jco.2014.57.4244

Dung T. Le Andrea Wang‐Gillam Vincent J. Picozzi Tim F. Greten

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors

2019 · European Journal of Cancer · 299 citations

https://doi.org/10.1016/j.ejca.2018.12.007

Andrea Wang‐Gillam Richard Hubner Jens T. Siveke Daniel D. Von Hoff

Results from a Phase IIb, Randomized, Multicenter Study of GVAX Pancreas and CRS-207 Compared with Chemotherapy in Adults with Previously Treated Metastatic Pancreatic Adenocarcinoma (ECLIPSE Study)

2019 · Clinical Cancer Research · 250 citations

https://doi.org/10.1158/1078-0432.ccr-18-2992

Dung T. Le Vincent J. Picozzi Andrew H. Ko Zev A. Wainberg

Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer

2014 · Cancer Immunology Immunotherapy · 216 citations

https://doi.org/10.1007/s00262-014-1527-x

Roheena Z. Panni Dominic E. Sanford Brian A. Belt Jonathan B. Mitchem

Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers

2024 · Science · 91 citations

https://doi.org/10.1126/science.adk0775

Jeffrey A. Klomp Jeffrey A. Klomp Jennifer E. Klomp Jennifer E. Klomp

A phase I study of MK-5108, an oral aurora a kinase inhibitor, administered both as monotherapy and in combination with docetaxel, in patients with advanced or refractory solid tumors

2015 · Investigational New Drugs · 43 citations

https://doi.org/10.1007/s10637-015-0306-7

Manik Amin Susan Minton Patricia LoRusso Smitha Krishnamurthi

Research topics

topics

Pancreatic and Hepatic Oncology Research

Cancer Immunotherapy and Biomarkers

Cancer Genomics and Diagnostics

Colorectal Cancer Treatments and Studies

Cancer Research and Treatments

Chat about Author

Papers

Chat

Click to start Chat